Skip to main content

Find Clinical Trials

Home
Conditions
Clinically Isolated Syndrome of Demyelination

Clinical trial condition

Clinically Isolated Syndrome of Demyelination

Explore clinical trials studying Clinically Isolated Syndrome of Demyelination. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Clinically Isolated Syndrome of Demyelination trial results

Recruiting

Natalizumab for the Treatment of People With Inflammatory Demyelination Suggestive of Multiple Sclerosis, or Definite Multiple Sclerosis, at First Presentation (AttackMS)

NCT05418010

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Charcot-Marie-Tooth disease, Type 1F, +6 more
Locations: Royal London Hospital London, United Kingdom

St George's Hospital London, United Kingdom

View Trial Details